Direct and indirect effects of aldosterone on cyclooxygenase-2 and interleukin-6 expression in rat cardiac cells in culture and after myocardial infarction

Endocrinology

Volumn 145, Issue 7, 2004, Pages 3135-3142

  Rebsamen, Michela C ^a   Perrier, Emeline ^b   Gerber Wicht, Christine ^a   Benitah, Jean Pierre ^b   Lang, Ursula ^a  

^a University Hospital   (Switzerland)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; CYCLOHEXIMIDE; CYCLOOXYGENASE 2; DACTINOMYCIN; INTERLEUKIN 6; MESSENGER RNA; MINERALOCORTICOID ANTAGONIST; OXPRENOATE POTASSIUM; PROSTAGLANDIN E2; SPIRONOLACTONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOCRINE EFFECT; CELL STIMULATION; CONTROLLED STUDY; ENZYME INDUCTION; FIBROBLAST; HEART INFARCTION; HEART MUSCLE CELL; IN VIVO STUDY; MALE; NEWBORN; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ALDOSTERONE; ANIMALS; BIOLOGICAL MARKERS; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROSTONE; FIBROBLASTS; GENE EXPRESSION; HEART VENTRICLES; INTERLEUKIN-6; ISOENZYMES; MALE; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, WISTAR;

EID: 3042645218     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-1544     Document Type: Article

References (44)

1. White PC 2003 Aldosterone: direct effects on and production by the heart. J Clin Endocrinol Metab 88:2376-2383
2. Funder JW 1997 Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance. Annu Rev Med 48:231-240
3. Funder J 2001 Mineralocorticoids and cardiac fibrosis: the decade in review. Clin Exp Pharmacol Physiol 28:1002-1006
4. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J 1999 The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341:709-717
5. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M 2003 Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309-1321
6. Benetos A, Lacolley P, Safar ME 1997 Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 17:1152-1156
7. Rocha R, Chander PN, Khanna K, Zuckerman A, Stier Jr CT 1998 Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats. Hypertension 31:451-458
8. Rocha R, Stier Jr CT, Kifor I, Ochoa-Maya MR, Rennke HG, Williams GH, Adler GK 2000 Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology 141:3871-3878
9. Brilla CG, Weber KT 1992 Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J Lab Clin Med 120:893-901
10. Robert V, Silvestre JS, Charlemagne D, Sabri A, Trouve P, Wassef M, Swynghedauw B, Delcayre C 1995 Biological determinants of aldosterone-induced cardiac fibrosis in rats. Hypertension 26:971-978
11. Rocha R, Martin-Berger CL, Yang P, Scherrer R, Delyani J, McMahon E 2002 Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart. Endocrinology 143:4828-4836
12. Gerling IC, Sun Y, Ahokas RA, Wodi LA, Bhattacharya SK, Warrington KJ, Postlethwaite AE, Weber KT 2003 Aldosteronism: an immunostimulatory state precedes proinflammatory/fibrogenic cardiac phenotype. Am J Physiol Heart Circ Physiol 285:H813-H821
13. Ahokas RA, Warrington KJ, Gerling IC, Sun Y, Wodi LA, Herring PA, Lu L, Bhattacharya SK, Postlethwaite AE, Weber KT 2003 Aldosteronism and peripheral blood mononuclear cell activation: a neuroendocrine-immune interface. Circ Res 93:e124-e135
14. Rocha R, Rudolph AE, Frierdich GE, Nachowiak DA, Kekec BK, Blomme EA, McMahon EG, Delyani JA 2002 Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am J Physiol Heart Circ Physiol 283:H1802-H1810
15. Diwan A, Tran T, Misra A, Mann DL 2003 Inflammatory mediators and the failing heart: a translational approach. Curr Mol Med 3:161-182
16. Paulus WJ 2000 Cytokines and heart failure. Heart Fail Monit 1:50-56
17. Silvestre JS, Heymes C, Oubenaissa A, Robert V, Aupetit-Faisant B, Carayon A, Swynghedauw B, Delcayre C 1999 Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation 99:2694-2701
18. Weber KT, Sun Y, Campbell SE, Slight SH, Ganjam VK, Griffing GT, Swinfard RW, Diaz-Arias AA 1995 Chronic mineralocorticoid excess and cardiovascular remodeling. Steroids 60:125-132
19. Saito T, Rodger IW, Shennib H, Hu F, Tayara L, Giaid A 2003 Cyclooxygenase-2 (COX-2) in acute myocardial infarction: cellular expression and use of selective COX-2 inhibitor. Can J Physiol Pharmacol 81:114-119
20. Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S 1998 Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation 98:149-156
21. Springhorn JP, Claycomb WC 1989 Preproenkephalin mRNA expression in developing rat heart and in cultured ventricular cardiac muscle cells. Biochem J 258:73-78
22. Sadoshima J, Izumo S 1993 Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 73:413-423
23. Alvarez JL, Aimond F, Lorente P, Vassort G 2000 Late post-myocardial infarction induces a tetrodotoxin-resistant Na(+) current in rat cardiomyocytes. J Mol Cell Cardiol 32:1169-1179
24. Agarwal MK, Mirshahi M 1999 General overview of mineralocorticoid hormone action. Pharmacol Ther 84:273-326
25. Benitah JP, Perrier E, Gomez AM, Vassort G 2001 Effects of aldosterone on transient outward K+ current density in rat ventricular myocytes. J Physiol 537:151-160
26. Kaprielian R, Wickenden AD, Kassiri Z, Parker TG, Liu PP, Backx PH 1999 Relationship between K+ channel down-regulation and [Ca2+]i in rat ventricular myocytes following myocardial infarction. J Physiol 517(Pt 1):229-245
27. DuBois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, van de Putte LB, Lipsky PE 1998 Cyclooxygenase in biology and disease. FASEB J 12:1063-1073
28. Slight S, Ganjam VK, Nonneman DJ, Weber KT 1993 Glucocorticoid metabolism in the cardiac interstitium: 11 β-hydroxysteroid dehydrogenase activity in cardiac fibroblasts. J Lab Clin Med 122:180-187
29. Kohler E, Bertschin S, Woodtli T, Resink T, Erne P 1996 Does aldosterone-induced cardiac fibrosis involve direct effects on cardiac fibroblasts? J Vasc Res 33:315-326
30. Stockand JD, Meszaros JG 2003 Aldosterone stimulates proliferation of cardiac fibroblasts by activating Ki-RasA and MAPK1/2 signaling. Am J Physiol Heart Circ Physiol 284:H176-H184
31. Gorgoni B, Caivano M, Arizmendi C, Poli V 2001 The transcription factor C/EBPβ is essential for inducible expression of the cox-2 gene in macrophages but not in fibroblasts. J Biol Chem 276:40769-40777
32. Degousee N, Martindale J, Stefanski E, Cieslak M, Lindsay TF, Fish JE, Marsden PA, Thuerauf DJ, Glembotski CC, Rubin BB 2003 MAP kinase kinase 6-p38 MAP kinase signaling cascade regulates cyclooxygenase-2 expression in cardiac myocytes in vitro and in vivo. Circ Res 92:757-764
33. Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Sawaki M, Fujii M, Matsumoto T, Kinoshita M 2000 Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor α, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure. J Am Coll Cardiol 35:714-721
34. Baumgarten G, Knuefermann P, Mann DL 2000 Cytokines as emerging targets in the treatment of heart failure. Trends Cardiovasc Med 10:216-223
35. Scheuren N, Jacobs M, Ertl G, Schorb W 2002 Cyclooxygenase-2 in myocardium stimulation by angiotensin-II in cultured cardiac fibroblasts and role at acute myocardial infarction. J Mol Cell Cardiol 34:29-37
36. Millet I, McCarthy TL, Vignery A 1998 Regulation of interleukin-6 production by prostaglandin E2 in fetal rat osteoblasts: role of protein kinase A signaling pathway. J Bone Miner Res 13:1092-1100
37. Williams JA, Pontzer CH, Shacter E 2000 Regulation of macrophage interleukin-6 (IL-6) and IL-10 expression by prostaglandin E2: the role of p38 mitogen-activated protein kinase. J Interferon Cytokine Res 20:291-298
38. Hinson RM, Williams JA, Shacter E 1996 Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2. Proc Natl Acad Sci USA 93:4885-4890
39. Tamura M, Sebastian S, Yang S, Gurates B, Ferrer K, Sasano H, Okamura K, Bulun SE 2002 Up-regulation of cyclooxygenase-2 expression and prostaglandin synthesis in endometrial stromal cells by malignant endometrial epithelial cells. A paracrine effect mediated by prostaglandin E2 and nuclear factor-κ B. J Biol Chem 277:26208-26216
40. Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC, Gregory SA 1996 Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 97:2672-2679
41. Stebbins CL, Smith RC, Longhurst JC 1985 Effect of prostaglandins on bradykinin-induced visceral-cardiac reflexes. Am J Physiol 249:H155-H163
42. Bradbury DA, Newton R, Zhu YM, El Haroun H/Corbett L, Knox AJ 2003 Cyclooxygenase-2 induction by bradykinin in human pulmonary artery smooth muscle cells is mediated by the cyclic AMP response element through a novel autocrine loop involving endogenous prostaglandin E2, E-prostanoid 2 (EP2), and EP4 receptors. J Biol Chem 278:49954-49964
43. Sano M, Fukuda K, Kodama H, Pan J, Saito M, Matsuzaki J, Takahashi T, Makino S, Kato T, Ogawa S 2000 Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J Biol Chem 275:29717-29723
44. Ancey C, Corbi P, Froger J, Delwail A, Wijdenes J, Gascan H, Potreau D, Lecron JC 2002 Secretion of IL-6, IL-11 and LIF by human cardiomyocytes in primary culture. Cytokine 18:199-205